Digitisation | September 29, 2023
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
The use of procalcitonin testing for sepsis management is highest in the US
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
The govt has rolled out three schemes for promoting the manufacture of API
For the full year FY25, net profit soared 12x to Rs 345 crore
Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
The company will initially supply prototypes to diverse customers to evaluate in purification processes for producing gene therapy drugs with a view to swift commercialization
Subscribe To Our Newsletter & Stay Updated
